This volume presents recent developments in the novel drug development
and potential of extremophilic cyanobacteria. It discusses how these
tiny organism originated, produce oxygen that leads to evolution of life
on the earth, how their survival strategies in extreme climatic
conditions lead to diverse metabolic pathways, and the opportunity to
use them to develop novel drugs. The book is comprised of five chapters,
starting with the origin of cyanobacteria, their survival strategies
under extreme conditions, and their capabilities to change metabolic
activities.The second chapter explores the different metabolic pathways
found in cyanobacteria and examines advances in this field and recent
techniques like MALDI-TOF imaging and metagenomics tools as well as in
silico techniques for rapid screening of secondary metabolites. Further
chapters cover the glycomics of cyanobacteria, anticancer drug
development, and some issues and challenges of using cyanobacteria to
develop drugs.
Extremophilic Cyanobacteria For Novel Drug Development provides
insight into future perspectives in drug development and is a key
resource for students, researchers and professionals in pharmacy,
medicinal chemistry, pharmacognosy biotechnology, biology, and
academics.